Workflow
ResMed(RMD)
icon
Search documents
ResMed(RMD) - 2021 Q2 - Earnings Call Presentation
2021-01-29 04:32
Q2 FY2021 Earnings January 28, 2021 Presentation of financial information & forward-looking statements Historical financial and operating data in this presentation reflect the consolidated results of ResMed Inc., its subsidiaries, and its legal entities, for the periods indicated. This presentation includes financial information prepared in accordance with accounting principles generally accepted in the United States, or GAAP, as well as other financial measures referred to as non-GAAP. The non-GAAP financi ...
ResMed(RMD) - 2021 Q2 - Earnings Call Transcript
2021-01-29 04:01
ResMed Inc. (NYSE:RMD) Q2 2021 Earnings Conference Call January 28, 2021 4:30 PM ET Company Participants Amy Wakeham - Vice President of Investor Relations and Corporate Communications Mick Farrell - Chief Executive Officer Brett Sandercock - Chief Financial Officer David Pendarvis - Secretary and Chief Administrative Officer James Hollings - President, Sleep and Respiratory Care Business Rob Douglas - Chief Operating Officer Conference Call Participants Margaret Kaczor - William Blair & Company David Baile ...
ResMed(RMD) - 2021 Q2 - Quarterly Report
2021-01-28 22:55
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ______________________________________________________________________________________________ FORM 10-Q ______________________________________________________________________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2020 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 F ...
ResMed(RMD) Presents At 39th Annual J.P. Morgan Healthcare Conference - Slideshow
2021-01-20 23:29
39th Annual J.P. Morgan Healthcare Conference Mick Farrell - CEO January 12, 2021 Presentation of financial information & forward-looking statements Historical financial and operating data in this presentation reflect the consolidated results of ResMed Inc., its subsidiaries, and its legal entities, for the periods indicated. This presentation includes financial information prepared in accordance with accounting principles generally accepted in the United States, or GAAP, as well as other financial measures ...